Bank of New York Mellon
ATYR

Bank of New York Mellon’s aTyr Pharma ATYR Stock Holding History

Bank of New York Mellon’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-193,531
Closed -$151K – 4451
2026
Q1 		$151K Sell
193,531
-1
-0% -$1 ﹤0.01% 4051
2025
Q4 		$152K Sell
193,532
-6,266
-3% -$5.14K ﹤0.01% 4068
2025
Q3 		$144K Buy
199,798
+13,904
+7% +$63K ﹤0.01% 4075
2025
Q2 		$942K Buy
+185,894
New +$731K ﹤0.01% 3158
2024
Q1 		– Sell
-16,426
Closed -$23.2K – 4327
2023
Q4 		$23.2K Hold
16,426
– – ﹤0.01% 4227
2023
Q3 		$26K Hold
16,426
– – ﹤0.01% 4225
2023
Q2 		$35.5K Sell
16,426
-19,442
-54% -$42.4K ﹤0.01% 4223
2023
Q1 		$75.3K Buy
+35,868
New +$78.6K ﹤0.01% 4121
2018
Q2 		– Sell
-1,824
Closed -$68K – 4321
2018
Q1 		$68K Sell
1,824
-74
-4% -$3.47K ﹤0.01% 4123
2017
Q4 		$93K Sell
1,898
-46
-2% -$2.83K ﹤0.01% 4112
2017
Q3 		$137K Hold
1,944
– – ﹤0.01% 3946
2017
Q2 		$93K Sell
1,944
-17
-0.9% -$796 ﹤0.01% 4042
2017
Q1 		$96K Hold
1,961
– – ﹤0.01% 4038
2016
Q4 		$59K Buy
1,961
+568
+41% +$23.3K ﹤0.01% 4111
2016
Q3 		$62K Buy
+1,393
New +$60.2K ﹤0.01% 4110
2016
Q2 		– Sell
-2,591
Closed -$143K – 4359
2016
Q1 		$143K Buy
2,591
+1,103
+74% +$83.8K ﹤0.01% 3884
2015
Q4 		$205K Hold
1,488
– – ﹤0.01% 3860
2015
Q3 		$214K Sell
1,488
-64
-4% -$14.6K ﹤0.01% 3882
2015
Q2 		$402K Buy
+1,552
New +$482K ﹤0.01% 3711

Other funds holding ATYR

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWM
Hohimer Wealth Management Seattle, Washington $1B AUM 33.02% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $183M AUM 8.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bank of New York Mellon's ATYR Position: Q2 2026 in Review

Bank of New York Mellon sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 193,531 shares — an estimated $151K sold.

Bank of New York Mellon first reported a position in ATYR in Q2 2015 and held it in 19 quarters. The position peaked at $942K in Q2 2025. 35 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Bank of New York Mellon reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 193,531 aTyr Pharma shares in Q2 2026, an estimated $151K.
  • Bank of New York Mellon first reported a position in aTyr Pharma in Q2 2015 and held it in 19 quarters.
  • Bank of New York Mellon's aTyr Pharma position peaked at $942K in Q2 2025.
  • 35 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.